indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
all-news

SRV Hospitals secures Rs 140 Cr from InvAscent

IMT News Desk

To augment the critical care-backed model

SRV Hospitals has raised Rs 140 crores from InvAscent, India’s leading life sciences private equity fund. The investment will enable SRV to strengthen and amplify its multispecialty critical care-focussed healthcare model. The funding positions SRV for its next chapter, setting new benchmarks in the healthcare sector, while deepening its commitment to advanced critical and surgical care, empowered clinicians, and elevated patient experience.

“We built SRV Hospitals with a vision of setting new standards in the critical and surgical care space, and those standards have now become our greatest strength,” said Dr Abhay Vispute, Director - SRV Hospitals. “This investment from InvAscent is a strategic alignment of purpose. Over these years, SRV has grown with intent, delivered excellence with consistency, and built trust with one patient, one family, and one neighbourhood at a time. This capital will strengthen our core and extend our impact.”

Sameer Pawar, CEO, SRV Hospitals, said, "Our mission is rooted in the belief that high-quality care should not be a privilege of geography. We’ve created hospital ecosystems that bring empathy, expertise, and innovation to people’s neighbourhoods. This investment allows us to strengthen our mission responsibly—with our people, our standards, and our commitment to trust at the centre of it all.”

“We are proud to partner with SRV Hospitals, a group that has a strong foundation and boasts a high-trust clinical network backed by a differentiated critical care model, and a leadership team that is not only clinically astute and operationally strong but deeply aligned with the long-term evolution of healthcare in this country,” said Dr Jeevak Gupta, Director – Investments,  InvAscent.

Recommended

Ethiopian delegation meets key representatives from DCGI and the Indian Pharmacopoeia Commission

Metropolis Healthcare data reveals 1 in 3 Indians show early signs of metabolic syndrome

Karnataka sees steady diabetes burden over a decade: Neuberg Diagnostics

National summit on Diabetic Retinopathy unveils new guidelines with support from Roche India

Glenmark registers consolidated revenue of Rs 60,469 Mn in Q2FY26

Delhi to host 18th edition of CPHI & PMEC India 2025 from Nov 25 to 27, 2025

Pathkind and WebEngage unite to deliver personalised, data-driven patient experiences

Akums reports consolidated revenue of Rs 1,018 crore in Q2 FY26

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions